Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Gary P. Wiesehahn
Laurence Corash
Diamond Scientific Co.
Miles Inc.
Bayer Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/350,335external-prioritypatent/US5176921A/en
Application filed by Gary P. Wiesehahn, Laurence Corash, Diamond Scientific Co., Miles Inc., Bayer CorporationfiledCriticalGary P. Wiesehahn
Publication of CA2015315A1publicationCriticalpatent/CA2015315A1/en
Application grantedgrantedCritical
Publication of CA2015315CpublicationCriticalpatent/CA2015315C/en
Biological compositions are freed of functional polynucleotides by treatment of the biological composition with psoralen derivatives under irradiation conditions in which the proteins retain their original physiological activities and any polynucleotide present is rendered inactive.
CA 20153151989-05-111990-04-24Improved method of blood component decontamination by glucose addition and post-decontamination gassing
Expired - LifetimeCA2015315C
(en)
Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components
Human tissue-type plasminogen activator having modified functional carbohydrate residues, which retains its biological activity and is characterized by an increased in vivo half-life